{
    "nct_id": "NCT04514692",
    "official_title": "Phase 1-2 Study of Individualized Bone Marrow Sparing Image Guided Radiotherapy Incorporating Novel Use of Granulocyte Colony Stimulating Factor and FDG PET Imaging",
    "inclusion_criteria": "* Gynecologic cancer patients receiving pelvic radiation and chemotherapy, specifically: 1) Stage I-IIIC1 cervix cancer, 2) stage I-III primary vaginal cancer, 3) stage IIIA-IIIC1 endometrial cancer patients status post hysterectomy and lymph node assessment, and 4) recurrent endometrial cancer patients with pelvic confined disease No required para-aortic or extended field radiation\n* Age > 18 years\n* ECOG performance status 0-2\n* Adequate kidney function (serum Cr <1.5 or creatinine clearance >50 mg/dl)\n* Adequate bone marrow function (white blood cells > 3.0 X 10^9/L, platelets >100 x 10^9/L)\n* Ability to understand and the willingness to sign a written informed consent document.\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Treatment for other cancer in the past 2 years\n* Previous pelvic radiation\n* Medical condition that prevents receiving chemotherapy",
    "miscellaneous_criteria": ""
}